Prognostic role of FGFR Mutations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second-line setting - Roghmann, F.; Wirtz, R.; Jarczyk, J.; Kriegmair, M. C.; Worst, T. S.; Sikic, D.; Wach, S.; Taubert, Helge; Wullich, Bernd; Weyerer, Veronika; Stöhr, Robert; Zengerling, F.; et al. (ANNALS OF ONCOLOGY, 2019)
CRIS-Team WoS Importer:2019-11-08